Search results
Results from the WOW.Com Content Network
The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.It later moved its headquarters to New Jersey. In 2004, BD agreed to pay out US$100 million to settle allegations from competitor Retractable Technologies that it had engaged in anti-competitive behavior to prevent the distribution of Retractable's syringes, which are designed to prevent needlestick ...
The Becton, Dickinson and Company Corporate Headquarters is a corporate campus in Franklin Lakes, New Jersey. Built between 1986 and 1992, the buildings serve as the corporate and divisional headquarters of the Becton, Dickinson (BD) medical technology company. Designed by the architecture firm Kallmann McKinnell & Wood, the complex has won ...
In September 2018, Thermo Fisher Scientific announced it had signed a definitive agreement with Becton, Dickinson and Company (BDX) to acquire their Advanced Bioprocessing business. This BD business had annualized revenue of approximately $100 million; as of October 16, 2018, it had been integrated into Thermo Fisher's Life Sciences Solutions ...
Source: Yahoo! Finance and Becton Dickinson home page. Strengths: Becton is a member of the S&P 500 Dividend Aristocrats -- S&P 500 companies that have raised their dividend every year for at ...
Medtronic is the top medical device company in the world for 2018 with an impressive annual revenue nearly $30 billion in 2017. The company experienced a 3% increase in revenue compared with 2016 figures and they reported 'balanced, diversified growth across all groups and regions'.
March 21, 2024 at 7:14 AM. (Reuters) -Becton Dickinson said on Thursday it has increased production of medical syringes in the United States after the country's drug regulator recommended not ...
July 10, 2024 at 9:53 AM. (Reuters) - The U.S. Food and Drug Administration issued an alert on Wednesday to laboratories and healthcare providers of a shortage of Becton Dickinson' blood test ...
In 2016, Aptar entered into an agreement with Becton Dickinson & Company to develop new self-injection devices. [16] [17] Aptar entered into an agreement in 2016 with Propeller Health Partners to develop a digitally connected medication inhaler. [18] The company made an investment in Propeller Health Partners (now part of Resmed) in 2018. [19]